Atlas Trials

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Clinical trial NCT03683680 · RECRUITING

Trial details

NCT number
NCT03683680
Sponsor
Dana-Farber Cancer Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Mesothelioma
Start date
2018-10-31
Primary completion
2030-01-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.